Literature DB >> 20139229

Comparison of pleural fluid N-terminal pro-brain natriuretic peptide and brain natriuretic-32 peptide levels.

Ann C Long1, Hollis R O'Neal, Suiwei Peng, Kirk B Lane, Richard W Light.   

Abstract

BACKGROUND: Current evidence indicates that measurement of pleural fluid N-terminal pro-brain natriuretic peptide (NT-proBNP) levels can aid in distinguishing pleural effusions of cardiac origin from those of noncardiac origin. To date, only one study, to our knowledge, has described simultaneous measurement of pleural fluid brain natriuretic-32 peptide (BNP) and NT-proBNP. The purpose of the present study was to determine pleural fluid BNP and NT-proBNP levels and analyze the relationship between these two measurements. We hypothesized that there would be a positive correlation between pleural fluid NT-proBNP and BNP, whereas NT-proBNP levels would be higher than BNP levels.
METHODS: Levels of pleural fluid NT-proBNP and BNP were measured by enzyme immunoassay in a total of 80 patients: 20 with congestive heart failure, 20 status post-coronary artery bypass graft, 20 with carcinoma, and 20 with pneumonia.
RESULTS: Comparison of NT-proBNP and BNP concentrations using the Spearman method of statistical analysis revealed a correlation coefficient of 0.572, P < .001. Evaluation of the diagnostic accuracy of BNP and NT-proBNP in patients with pleural effusions of cardiac origin demonstrated an area under the receiver operating characteristic curve of 0.700 (95% CI, 0.569-0.831) and 0.835 (95% CI, 0.721-0.949), respectively.
CONCLUSIONS: Although levels of pleural fluid BNP have a statistically significant correlation with those of NT-proBNP, this relationship only explains 32% of the variance in NT-proBNP levels. Furthermore, when compared with BNP, NT-proBNP is a more accurate diagnostic aid in the evaluation of pleural effusions of cardiac origin.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20139229      PMCID: PMC2881629          DOI: 10.1378/chest.09-2193

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  14 in total

1.  Comparison of the Biomedica NT-proBNP enzyme immunoassay and the Roche NT-proBNP chemiluminescence immunoassay: implications for the prediction of symptomatic and asymptomatic structural heart disease.

Authors:  Thomas Mueller; Alfons Gegenhuber; Werner Poelz; Meinhard Haltmayer
Journal:  Clin Chem       Date:  2003-06       Impact factor: 8.327

2.  Measurement of pro-brain natriuretic peptide in pleural fluid for the diagnosis of pleural effusions due to heart failure.

Authors:  José Manuel Porcel; Manuel Vives; Gonzalo Cao; Aureli Esquerda; Manuel Rubio; M Carmen Rivas
Journal:  Am J Med       Date:  2004-03-15       Impact factor: 4.965

Review 3.  Natriuretic peptides in the diagnosis and management of heart failure.

Authors:  G Michael Felker; John W Petersen; Daniel B Mark
Journal:  CMAJ       Date:  2006-09-12       Impact factor: 8.262

4.  National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine practice guidelines: Analytical issues for biomarkers of heart failure.

Authors:  Fred S Apple; Alan H B Wu; Allan S Jaffe; Mauro Panteghini; Robert H Christenson; Christopher P Cannon; Gary Francis; Robert L Jesse; David A Morrow; L Kristen Newby; Alan B Storrow; W H Wilson Tang; Franca Pagani; Jillian Tate; Jordi Ordonez-Llanos; Johannes Mair
Journal:  Circulation       Date:  2007-07-14       Impact factor: 29.690

5.  Quality specifications for B-type natriuretic peptide assays.

Authors:  Fred S Apple; Mauro Panteghini; Jan Ravkilde; Johannes Mair; Alan H B Wu; Jillian Tate; Franca Pagani; Robert H Christenson; Allan S Jaffe
Journal:  Clin Chem       Date:  2005-03       Impact factor: 8.327

6.  The role of the circulation in processing pro-brain natriuretic peptide (proBNP) to amino-terminal BNP and BNP-32.

Authors:  P J Hunt; E A Espiner; M G Nicholls; A M Richards; T G Yandle
Journal:  Peptides       Date:  1997       Impact factor: 3.750

Review 7.  NT-ProBNP: the mechanism behind the marker.

Authors:  Christian Hall
Journal:  J Card Fail       Date:  2005-06       Impact factor: 5.712

8.  Stability of B-type natriuretic peptide (BNP) in whole blood and plasma stored under different conditions when measured with the Biosite Triage or Beckman-Coulter Access systems.

Authors:  Hassan M E Azzazy; Robert H Christenson; Show Hong Duh
Journal:  Clin Chim Acta       Date:  2007-06-16       Impact factor: 3.786

9.  Biomarkers of heart failure in pleural fluid.

Authors:  José M Porcel; Montserrat Martínez-Alonso; Gonzalo Cao; Silvia Bielsa; Ana Sopena; Aureli Esquerda
Journal:  Chest       Date:  2009-04-10       Impact factor: 9.410

10.  NT-brain natriuretic peptide levels in pleural fluid distinguish between pleural transudates and exudates.

Authors:  János Tomcsányi; Erzsébet Nagy; Miklós Somlói; Judit Moldvay; Attila Bezzegh; Béla Bózsik; János Strausz
Journal:  Eur J Heart Fail       Date:  2004-10       Impact factor: 15.534

View more
  5 in total

Review 1.  Diagnostic accuracy of pleural fluid NT-pro-BNP for pleural effusions of cardiac origin: a systematic review and meta-analysis.

Authors:  Surinder Janda; John Swiston
Journal:  BMC Pulm Med       Date:  2010-11-20       Impact factor: 3.317

2.  Pleural fluid analysis: standstill or a work in progress?

Authors:  T Hassan; M Al-Alawi; S H Chotirmall; N G McElvaney
Journal:  Pulm Med       Date:  2012-02-01

Review 3.  Diagnostic Accuracy of Natriuretic Peptides for Heart Failure in Patients with Pleural Effusion: A Systematic Review and Updated Meta-Analysis.

Authors:  Zhi-Jun Han; Xiao-Dan Wu; Juan-Juan Cheng; Shi-Di Zhao; Ming-Zhu Gao; Hong-Yu Huang; Bing Gu; Ping Ma; Yan Chen; Jun-Hong Wang; Cheng-Jian Yang; Zi-He Yan
Journal:  PLoS One       Date:  2015-08-05       Impact factor: 3.240

4.  Cautious application of pleural N-terminal pro-B-type natriuretic peptide in diagnosis of congestive heart failure pleural effusions among critically ill patients.

Authors:  Jiann-Horng Yeh; Chun-Ta Huang; Chia-Hsiung Liu; Sheng-Yuan Ruan; Yi-Ju Tsai; Ying-Chun Chien; Ching-Yao Yang; Chun-Kai Huang; Chia-Lin Hsu; Lu-Cheng Kuo; Pei-Lin Lee; Shih-Chi Ku; Ping-Hung Kuo; Chong-Jen Yu
Journal:  PLoS One       Date:  2014-12-12       Impact factor: 3.240

5.  Assessment of a bedside test for N-terminal pro B-type natriuretic peptide (NT-proBNP) to differentiate cardiac from non-cardiac causes of pleural effusion in cats.

Authors:  Gabriel Wurtinger; Estelle Henrich; Nicolai Hildebrandt; Nicola Wiedemann; Matthias Schneider; Esther Hassdenteufel
Journal:  BMC Vet Res       Date:  2017-12-20       Impact factor: 2.741

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.